NO323567B1 - Prosess for krystallisering av forbindelser med sterisk hindring - Google Patents

Prosess for krystallisering av forbindelser med sterisk hindring Download PDF

Info

Publication number: NO323567B1
Authority: NO; Norway
Prior art keywords: crystallization; solvent; solution; compound; boiling point
Prior art date: 1997-10-02

Application number

NO20001470A

Other languages

English (en)

Norwegian (no)

Other versions

NO20001470L (no

NO20001470D0 (no

Inventor

Jan Cervenka

Original Assignee

Ge Healthcare

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-02

Filing date

2000-03-22

Publication date

2007-06-11

2000-03-22 Application filed by Ge Healthcare filed Critical Ge Healthcare

2000-03-22 Publication of NO20001470L publication Critical patent/NO20001470L/no

2000-03-22 Publication of NO20001470D0 publication Critical patent/NO20001470D0/no

2007-06-11 Publication of NO323567B1 publication Critical patent/NO323567B1/no

Links

238000002425 crystallisation Methods 0.000 title claims abstract description 37
150000001875 compounds Chemical class 0.000 title claims abstract description 31
238000000034 method Methods 0.000 title claims abstract description 27
230000008025 crystallization Effects 0.000 title claims description 35
239000002904 solvent Substances 0.000 claims abstract description 29
238000009835 boiling Methods 0.000 claims abstract description 25
150000002894 organic compounds Chemical class 0.000 claims abstract description 6
229920006395 saturated elastomer Polymers 0.000 claims abstract description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 11
229960004359 iodixanol Drugs 0.000 claims description 10
NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 claims description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 claims description 4
229960001025 iohexol Drugs 0.000 claims description 4
239000000203 mixture Substances 0.000 claims description 4
150000004292 cyclic ethers Chemical class 0.000 claims description 2
239000013078 crystal Substances 0.000 description 9
239000011877 solvent mixture Substances 0.000 description 8
239000000126 substance Substances 0.000 description 6
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
-1 alcohol ethers Chemical class 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
230000004913 activation Effects 0.000 description 4
239000002872 contrast media Substances 0.000 description 4
XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 4
229960004647 iopamidol Drugs 0.000 description 4
238000010992 reflux Methods 0.000 description 4
XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
230000007704 transition Effects 0.000 description 3
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
238000001816 cooling Methods 0.000 description 2
239000000539 dimer Substances 0.000 description 2
150000002170 ethers Chemical class 0.000 description 2
125000006303 iodophenyl group Chemical group 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
150000002576 ketones Chemical class 0.000 description 2
239000000463 material Substances 0.000 description 2
239000000178 monomer Substances 0.000 description 2
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
238000000746 purification Methods 0.000 description 2
KZYHGCLDUQBASN-UHFFFAOYSA-N 1-n,1-n,3-n,3-n,5-n,5-n-hexakis(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3,5-tricarboxamide Chemical compound OCCN(CCO)C(=O)C1=C(I)C(C(=O)N(CCO)CCO)=C(I)C(C(=O)N(CCO)CCO)=C1I KZYHGCLDUQBASN-UHFFFAOYSA-N 0.000 description 1
HVSOUCGIMNXGCY-UHFFFAOYSA-N 2-[[2-[2-[2-[2-(2-carboxy-3,5,6-triiodoanilino)-2-oxoethoxy]ethoxy]ethoxy]acetyl]amino]-3,4,6-triiodobenzoic acid Chemical compound OC(=O)C1=C(I)C=C(I)C(I)=C1NC(=O)COCCOCCOCC(=O)NC1=C(I)C(I)=CC(I)=C1C(O)=O HVSOUCGIMNXGCY-UHFFFAOYSA-N 0.000 description 1
OQHLOKBHRXMXLD-UHFFFAOYSA-N 5-[3-[3-[3,5-bis[2,3-dihydroxypropyl(methyl)carbamoyl]-2,4,6-triiodoanilino]-3-oxopropyl]sulfanylpropanoylamino]-1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1-n,3-n-dimethylbenzene-1,3-dicarboxamide Chemical compound OCC(O)CN(C)C(=O)C1=C(I)C(C(=O)N(CC(O)CO)C)=C(I)C(NC(=O)CCSCCC(=O)NC=2C(=C(C(=O)N(C)CC(O)CO)C(I)=C(C(=O)N(C)CC(O)CO)C=2I)I)=C1I OQHLOKBHRXMXLD-UHFFFAOYSA-N 0.000 description 1
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
SMQYOVYWPWASGU-UHFFFAOYSA-N Iocarmic acid Chemical compound OC(=O)C1=C(I)C(C(=O)NC)=C(I)C(NC(=O)CCCCC(=O)NC=2C(=C(C(=O)NC)C(I)=C(C(O)=O)C=2I)I)=C1I SMQYOVYWPWASGU-UHFFFAOYSA-N 0.000 description 1
WWVAPFRKZMUPHZ-UHFFFAOYSA-N Iodoxamic acid Chemical compound OC(=O)C1=C(I)C=C(I)C(NC(=O)CCOCCOCCOCCOCCC(=O)NC=2C(=C(C(O)=O)C(I)=CC=2I)I)=C1I WWVAPFRKZMUPHZ-UHFFFAOYSA-N 0.000 description 1
OIRFJRBSRORBCM-UHFFFAOYSA-N Iopanoic acid Chemical compound CCC(C(O)=O)CC1=C(I)C=C(I)C(N)=C1I OIRFJRBSRORBCM-UHFFFAOYSA-N 0.000 description 1
UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 description 1
XUHXFSYUBXNTHU-UHFFFAOYSA-N Iotrolan Chemical compound IC=1C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C=1N(C)C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I XUHXFSYUBXNTHU-UHFFFAOYSA-N 0.000 description 1
AMDBBAQNWSUWGN-UHFFFAOYSA-N Ioversol Chemical compound OCCN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I AMDBBAQNWSUWGN-UHFFFAOYSA-N 0.000 description 1
XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
BAQCROVBDNBEEB-UBYUBLNFSA-N Metrizamide Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(=O)N[C@@H]2[C@H]([C@H](O)[C@@H](CO)OC2O)O)=C1I BAQCROVBDNBEEB-UBYUBLNFSA-N 0.000 description 1
AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical class CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
125000004442 acylamino group Chemical group 0.000 description 1
125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 1
239000012296 anti-solvent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
229960005423 diatrizoate Drugs 0.000 description 1
238000004821 distillation Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
239000003999 initiator Substances 0.000 description 1
229960004901 iodamide Drugs 0.000 description 1
VVDGWALACJEJKG-UHFFFAOYSA-N iodamide Chemical compound CC(=O)NCC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I VVDGWALACJEJKG-UHFFFAOYSA-N 0.000 description 1
229960002487 iodoxamic acid Drugs 0.000 description 1
229960000780 iomeprol Drugs 0.000 description 1
NJKDOADNQSYQEV-UHFFFAOYSA-N iomeprol Chemical compound OCC(=O)N(C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NJKDOADNQSYQEV-UHFFFAOYSA-N 0.000 description 1
OLAOYPRJVHUHCF-UHFFFAOYSA-N iooxitalamic acid Chemical compound CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(C(=O)NCCO)=C1I OLAOYPRJVHUHCF-UHFFFAOYSA-N 0.000 description 1
229940074884 iopanoate Drugs 0.000 description 1
IUNJANQVIJDFTQ-UHFFFAOYSA-N iopentol Chemical compound COCC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I IUNJANQVIJDFTQ-UHFFFAOYSA-N 0.000 description 1
229960000824 iopentol Drugs 0.000 description 1
229960002603 iopromide Drugs 0.000 description 1
DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 1
229950011065 iosimide Drugs 0.000 description 1
229950011097 iotasul Drugs 0.000 description 1
229940029378 iothalamate Drugs 0.000 description 1
229960003182 iotrolan Drugs 0.000 description 1
229960004537 ioversol Drugs 0.000 description 1
229940029407 ioxaglate Drugs 0.000 description 1
TYYBFXNZMFNZJT-UHFFFAOYSA-N ioxaglic acid Chemical compound CNC(=O)C1=C(I)C(N(C)C(C)=O)=C(I)C(C(=O)NCC(=O)NC=2C(=C(C(=O)NCCO)C(I)=C(C(O)=O)C=2I)I)=C1I TYYBFXNZMFNZJT-UHFFFAOYSA-N 0.000 description 1
229960003781 ioxitalamic acid Drugs 0.000 description 1
ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
229960000554 metrizamide Drugs 0.000 description 1
229960004712 metrizoic acid Drugs 0.000 description 1
GGGDNPWHMNJRFN-UHFFFAOYSA-N metrizoic acid Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I GGGDNPWHMNJRFN-UHFFFAOYSA-N 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Inorganic Compounds Of Heavy Metals (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Epoxy Compounds (AREA)
Peptides Or Proteins (AREA)
Cephalosporin Compounds (AREA)
Glass Compositions (AREA)
Iron Core Of Rotating Electric Machines (AREA)

NO20001470A 1997-10-02 2000-03-22 Prosess for krystallisering av forbindelser med sterisk hindring NO323567B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9720969.6A GB9720969D0 (en)	1997-10-02	1997-10-02	Process
PCT/GB1998/002955 WO1999018054A1 (en)	1997-10-02	1998-10-02	Process for the crystallisation of sterically hindered compounds

Publications (3)

Publication Number	Publication Date
NO20001470L NO20001470L (no)	2000-03-22
NO20001470D0 NO20001470D0 (no)	2000-03-22
NO323567B1 true NO323567B1 (no)	2007-06-11

Family

ID=10819971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001470A NO323567B1 (no)	1997-10-02	2000-03-22	Prosess for krystallisering av forbindelser med sterisk hindring

Country Status (14)

Country	Link
US (1)	US6646171B2 (cs)
EP (1)	EP1025067B1 (cs)
JP (1)	JP4509375B2 (cs)
CN (1)	CN1129566C (cs)
AT (1)	ATE273945T1 (cs)
AU (1)	AU9274898A (cs)
CA (1)	CA2305569A1 (cs)
CZ (1)	CZ295010B6 (cs)
DE (1)	DE69825772T2 (cs)
ES (1)	ES2227875T3 (cs)
GB (1)	GB9720969D0 (cs)
NO (1)	NO323567B1 (cs)
PT (1)	PT1025067E (cs)
WO (1)	WO1999018054A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6957220B2 (en)	2000-11-07	2005-10-18	Research Investment Networks, Inc.	System, method and article of manufacture for tracking and supporting the distribution of content electronically
US7191442B2 (en)	2000-10-30	2007-03-13	Research Investment Network, Inc.	BCA writer serialization management
ITMI20010773A1 (it) *	2001-04-11	2002-10-11	Chemi Spa	Processo per la produzione di ioexolo ad elevata purezza
NO20043305D0 (no) *	2004-08-09	2004-08-09	Amersham Health As	Preparation of lodixanol
NO338295B1 (no) *	2004-08-09	2016-08-08	Ge Healthcare As	Fremstilling av iodixanol.
NO20053676D0 (no) *	2005-07-29	2005-07-29	Amersham Health As	Crystallisation Process
NO342021B1 (no) *	2005-07-29	2018-03-12	Ge Healthcare As	Kontinuerlig krystalliseringsprosess
NO20053687D0 (no) *	2005-07-29	2005-07-29	Amersham Health As	Crystallisation Process.
NO20055643D0 (no) *	2005-11-29	2005-11-29	Amersham Health As	Preparation of lodixanol
DE102005059191B4 (de) *	2005-12-05	2008-02-07	Bayer Schering Pharma Ag	Verfahren zur Rückgewinnung von für pharmazeutische Zwecke geeignetem Iopromid aus Mutterlaugen
CA2630413C (en) *	2005-12-05	2013-06-25	Bayer Schering Pharma Aktiengesellschaft	Process for recovery of iopromide, suitable for pharmaceutical purposes, from mother liquors
US7723544B2 (en) *	2005-12-08	2010-05-25	Bayer Schering Pharma Ag	Process for recovery of iopromide, suitable for pharmaceutical purposes, from mother liquors
US7968745B2 (en)	2005-12-19	2011-06-28	Ge Healthcare As	Purification process of iodixanol
CN101293855B (zh) *	2007-04-27	2012-08-29	上海冠杰生物医药科技有限公司	一种碘克沙醇的纯化方法
KR100976097B1 (ko)	2008-12-05	2010-08-16	주식회사 대웅제약	이오프로마이드의 ｚ 이성체를 선택적으로 결정화하는 방법
US8962887B2 (en) *	2009-07-21	2015-02-24	Ge Healthcare As	Synthesis of iodixanol in 1-methoxy-2-propanol and water or methanol
US8962886B2 (en) *	2009-07-21	2015-02-24	Ge Healthcare As	Synthesis of iodixanol in methanol
US8969619B2 (en)	2009-07-21	2015-03-03	Ge Healthcare As	Synthesis of iodixanol in propyleneglycol
US7754918B1 (en) *	2009-07-21	2010-07-13	Ge Healthcare As	Crystallization of iodixanol in isopropanol and methanol
US7999135B2 (en) *	2009-07-21	2011-08-16	Ge Healthcare As	Crystallization of iodixanol using ultrasound
US7999134B2 (en)	2009-07-21	2011-08-16	Ge Healthcare As	Crystallization of iodixanol using milling
CN102079716B (zh) *	2009-11-26	2014-03-05	浙江台州海神制药有限公司	碘克沙醇的制备与纯化
EP2504298B1 (en) *	2009-11-26	2016-09-21	iMAX Diagnostic Imaging Holding Limited	Preparation and purification of iodixanol
CN102875411A (zh) *	2012-10-30	2013-01-16	广州牌牌生物科技有限公司	一种用大孔树脂分离纯化碘克沙醇注射剂原料的方法
CN111777525B (zh) *	2019-04-04	2021-08-27	成都西岭源药业有限公司	一种碘克沙醇的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1548594A (en) *	1976-06-11	1979-07-18	Nyegaard & Co As	Triiodoisophthalic acid amides
EP0108638B1 (en) *	1982-11-08	1986-07-16	NYEGAARD & CO. A/S	X-ray contrast agents
IL110391A (en) *	1993-07-30	1998-12-06	Zambon Spa	Process for the crystallization of iopamidol
DE4425340A1 (de) *	1994-07-18	1994-12-01	Ciba Geigy Ag	Sterisch gehinderte Amine in neuen kristallinen und amorphen Modifikationen
PT101720A (pt) *	1995-06-08	1997-01-31	Hovione Sociedade Quimica S A	Processo para a purificacao e cristalizacao de iopamidol

1997
- 1997-10-02 GB GBGB9720969.6A patent/GB9720969D0/en not_active Ceased
1998
- 1998-10-02 AU AU92748/98A patent/AU9274898A/en not_active Abandoned
- 1998-10-02 ES ES98945420T patent/ES2227875T3/es not_active Expired - Lifetime
- 1998-10-02 CN CN98809827A patent/CN1129566C/zh not_active Expired - Lifetime
- 1998-10-02 AT AT98945420T patent/ATE273945T1/de not_active IP Right Cessation
- 1998-10-02 CA CA002305569A patent/CA2305569A1/en not_active Abandoned
- 1998-10-02 JP JP2000514867A patent/JP4509375B2/ja not_active Expired - Lifetime
- 1998-10-02 PT PT98945420T patent/PT1025067E/pt unknown
- 1998-10-02 EP EP98945420A patent/EP1025067B1/en not_active Expired - Lifetime
- 1998-10-02 WO PCT/GB1998/002955 patent/WO1999018054A1/en not_active Ceased
- 1998-10-02 CZ CZ20001169A patent/CZ295010B6/cs not_active IP Right Cessation
- 1998-10-02 DE DE69825772T patent/DE69825772T2/de not_active Expired - Lifetime
2000
- 2000-03-22 NO NO20001470A patent/NO323567B1/no not_active IP Right Cessation
2001
- 2001-11-13 US US09/986,974 patent/US6646171B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2305569A1 (en)	1999-04-15
ATE273945T1 (de)	2004-09-15
PT1025067E (pt)	2004-11-30
DE69825772T2 (de)	2005-08-25
JP2001519320A (ja)	2001-10-23
CN1129566C (zh)	2003-12-03
NO20001470L (no)	2000-03-22
CZ20001169A3 (cs)	2000-09-13
AU9274898A (en)	1999-04-27
GB9720969D0 (en)	1997-12-03
ES2227875T3 (es)	2005-04-01
EP1025067A1 (en)	2000-08-09
NO20001470D0 (no)	2000-03-22
US6646171B2 (en)	2003-11-11
DE69825772D1 (de)	2004-09-23
EP1025067B1 (en)	2004-08-18
CN1273574A (zh)	2000-11-15
WO1999018054A1 (en)	1999-04-15
US20020072639A1 (en)	2002-06-13
CZ295010B6 (cs)	2005-05-18
JP4509375B2 (ja)	2010-07-21

Legal Events

Date	Code	Title	Description
2018-11-12	MK1K	Patent expired

Publication	Publication Date	Title
US6646171B2 (en)	2003-11-11	Process for the crystallization of sterically hindered compounds
JP2001519320A5 (cs)	2006-10-26
NO342096B1 (no)	2018-03-19	Kontinuerlig krystalliseringsprosess
US8163965B2 (en)	2012-04-24	Continuous crystallisation process of iodinated phenyl derivatives
EP1960349B1 (en)	2015-11-18	Purification of iodixanol
MX2007001624A (es)	2008-10-27	Preparacion de iodixanol.
HUP9904325A2 (hu)	2000-04-28	Eljárás johexol előállítására
US7968745B2 (en)	2011-06-28	Purification process of iodixanol
CA2707173C (en)	2011-08-02	Crystallization of iodixanol in isopropanol and methanol
NO342021B1 (no)	2018-03-12	Kontinuerlig krystalliseringsprosess
HK1203476B (en)	2017-11-17	Continuous crystallization process of iodinated phenyl derivatives